Tangen Biosciences, Inc.
- UEI
- K3D1V93LH4F8
- CAGE
- 6ZYQ1
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$38 |
| FY2025 | -$500 |
| FY2024 | -$296,000 |
| FY2023 | -$353,000 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid detection of multiple sepsis pathogens | National Institutes of Health | $94,657 | |
| Rapid detection of multiple drug resistant TB from sputum | National Institutes of Health | $195,258 |
Similar vendors
About the company
Tangen Biosciences, Inc. is a for-profit corporation registered as a small disadvantaged business and manufacturer of goods. It provides biomedical assays and technologies to federal agencies like the Department of Health and Human Services (HHS).
Through prime federal contracts, Tangen has provided the National Institutes of Health (NIH) with scaling up production capabilities for its Tangen assay, a $2.68 million firm fixed price award from 2021-2023. For the Office of the Assistant Secretary for Preparedness and Response, Tangen delivered its TANGEN SARS-COV-2 assay under a $696,000 firm fixed price COVID-19 contract in 2020 to mitigate respiratory effects. No set-asides or subcontractors were indicated in these prime awards.
As a sub-recipient, Tangen received grant funding from the NIH RADx program via a sub-award from The General Hospital Corporation. This project aimed to validate Tangen's semi-automated wax station TB402 to increase production of rotors used in its assays from 2,000 to 20,000 per shift. Activities included installation qualification, operational and performance qualification, developing requirements specifications, and a final validation report. The project facilitated scaling up Tangen's wax spotting process for consistent small-volume wax dispensing into assay wells to streamline workflows.
Quick answers
Is Tangen Biosciences, Inc. registered in SAM.gov?
Tangen Biosciences, Inc.'s SAM.gov registration expired on October 25, 2023.
What is Tangen Biosciences, Inc.'s most recent federal award?
Tangen Biosciences, Inc.'s most recent federal contract award is Definitive Contract 75N92022C00001, from National Heart Lung and Blood Institute (NIH), on November 23, 2021.
On GovTribe
See Tangen Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors